Topoisomerase I inhibitors: topotecan and irinotecan

Cancer Pract. 1996 Jan-Feb;4(1):51-3.

Authors

S F Jones¹, H A Burris 3rd

Affiliation

¹ Tyler Hematology-Oncology, Texas, USA.

PMID: 8788772

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Antineoplastic Agents, Phytogenic / pharmacology
Antineoplastic Agents, Phytogenic / therapeutic use*
Camptothecin / analogs & derivatives*
Camptothecin / pharmacology
Camptothecin / therapeutic use
Clinical Trials, Phase I as Topic
Humans
Irinotecan
Topotecan

Substances

Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Irinotecan
Topotecan
Camptothecin